ARL2 p.Leu165Val
c.493C>G · VCV3430153
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2117 | likely benign |
|---|---|---|
| REVEL | 0.673 | pathogenic-leaning |
| SaProt | LLR -10.54 | damaging |
| ⇒ REVEL and SaProt call this damaging; AlphaMissense does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.9 | GERP 0.64, phastCons 1 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 7,644 bp · p 0.081 · regional, not allelic |
| Overall | ||
| CADD | 23.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0312% | 3,207 |
| Remaining individualsnot grpmax-eligible | 0.0064% | 15,619 |
| Admixed American | 0.00167% | 59,996 |
| European (non-Finnish) | 0.000169% | 589,984 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ARL2
- Protein
- p.Leu165Val
- Coding
- c.493C>G
- MANE Select
- NM_001667
- Type
- single nucleotide variant
- Location
- chr11:65021793 (GRCh38)
- Gene constraint
- LOEUF 0.935 · pLI 0.02 (gnomAD)
- Structure
- AlphaFold pLDDT 94.31 · 8 PDB
- Residue 165
- an α-helix
Similar variants
- ARL2 p.Arg139His Uncertain significance ★ ⚠ same type
- ARL2 p.Arg148Cys Uncertain significance ★ ⚠ same type
- ARL2 p.Arg148His Uncertain significance ★ ⚠ same type
- ARL2 p.Arg179Cys Uncertain significance ★ ⚠ same type
- ARL2 p.Arg179His Uncertain significance ★ ⚠ same type
- ARL2 p.Arg74Gln Uncertain significance ★ ⚠ same type
- ARL2 p.Arg98His Uncertain significance ★ ⚠ same type
- ARL2 p.Asp128Glu Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/arl2-p-leu165val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown